Harbin Gloria Pharmaceuticals Financial Flexibility Index

Latest as of September 2025: 0.22x

Harbin Gloria Pharmaceuticals financial flexibility index. Harbin Gloria Pharmaceuticals (002437) has a Financial Flexibility Index of 0.22x as of September 2025. Free cash flow of CN¥187.15 Million (operating CF CN¥182.89 Million minus capex CN¥4.26 Million) represents 0% of total liabilities (CN¥852.18 Million). See free cash flow generation of Harbin Gloria Pharmaceuticals to measure how efficiently the company converts operating cash flow to free cash.

Financial Flexibility Index

0.22x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥187.15 Million
Operating CF − Capex

Total Liabilities

CN¥852.18 Million
CNY

Capital Expenditures

CN¥4.26 Million
CNY

Financial Flexibility Index of Harbin Gloria Pharmaceuticals (2007–2025)

Financial flexibility index of Harbin Gloria Pharmaceuticals from 2007 to 2025. Historical Financial Flexibility Index trend for Harbin Gloria Pharmaceuticals across 19 annual periods. Check 002437 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Harbin Gloria Pharmaceuticals Financial Flexibility Index by Year (2007–2025)

Harbin Gloria Pharmaceuticals financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for Harbin Gloria Pharmaceuticals. For the full cash flow conversion analysis, see cash flow conversion of Harbin Gloria Pharmaceuticals.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2025 0.36x CN¥297.17 Million CN¥273.36 Million CN¥825.00 Million ▼ -35.2%
2024 0.56x CN¥473.83 Million CN¥410.94 Million CN¥852.26 Million ▲ +163.9%
2023 0.21x CN¥303.80 Million CN¥274.18 Million CN¥1.44 Billion ▲ +69.5%
2022 0.12x CN¥294.63 Million CN¥261.62 Million CN¥2.37 Billion ▲ +9.4%
2021 0.11x CN¥308.69 Million CN¥274.18 Million CN¥2.72 Billion ▲ +420.3%
2020 0.02x CN¥56.43 Million CN¥12.76 Million CN¥2.58 Billion ▼ -84.0%
2019 0.14x CN¥658.79 Million CN¥610.37 Million CN¥4.82 Billion ▼ -45.2%
2018 0.25x CN¥1.27 Billion CN¥1.16 Billion CN¥5.08 Billion ▲ +41.7%
2017 0.18x CN¥846.43 Million CN¥651.80 Million CN¥4.81 Billion ▼ -33.7%
2016 0.27x CN¥1.23 Billion CN¥1.04 Billion CN¥4.62 Billion ▲ +30.5%
2015 0.20x CN¥985.14 Million CN¥702.05 Million CN¥4.85 Billion ▼ -53.7%
2014 0.44x CN¥799.93 Million CN¥674.04 Million CN¥1.82 Billion ▼ -66.9%
2013 1.33x CN¥616.37 Million CN¥453.02 Million CN¥464.60 Million ▼ -22.8%
2012 1.72x CN¥350.25 Million CN¥205.89 Million CN¥203.79 Million ▼ -33.2%
2011 2.57x CN¥295.51 Million CN¥128.61 Million CN¥114.91 Million ▼ -46.4%
2010 4.79x CN¥353.47 Million CN¥112.59 Million CN¥73.73 Million ▲ +219.8%
2009 1.50x CN¥232.29 Million CN¥170.82 Million CN¥154.95 Million ▲ +33.2%
2008 1.13x CN¥95.89 Million CN¥57.81 Million CN¥85.17 Million ▲ +32.7%
2007 0.85x CN¥65.44 Million CN¥52.26 Million CN¥77.15 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities